SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 219 filers reported holding SEATTLE GENETICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $491,191,000 | +157.3% | 2,510,044 | +123.4% | 0.19% | +142.3% |
| Q2 2020 | $190,913,000 | +133.3% | 1,123,543 | +58.4% | 0.08% | +95.0% |
| Q1 2020 | $81,827,000 | +21.4% | 709,192 | +20.2% | 0.04% | +53.8% |
| Q4 2019 | $67,415,000 | +32.8% | 590,011 | -0.8% | 0.03% | +23.8% |
| Q3 2019 | $50,772,000 | +34.3% | 594,524 | +8.8% | 0.02% | +40.0% |
| Q2 2019 | $37,811,000 | +3636.3% | 546,315 | +3853.6% | 0.02% | +200.0% |
| Q1 2019 | $1,012,000 | +29.2% | 13,818 | 0.0% | 0.01% | 0.0% |
| Q4 2018 | $783,000 | -26.0% | 13,818 | +0.7% | 0.01% | -16.7% |
| Q3 2018 | $1,058,000 | +52.0% | 13,718 | +5.4% | 0.01% | +50.0% |
| Q4 2017 | $696,000 | -1.7% | 13,012 | 0.0% | 0.00% | -20.0% |
| Q3 2017 | $708,000 | +7.6% | 13,012 | +2.2% | 0.01% | +25.0% |
| Q2 2017 | $658,000 | -56.8% | 12,726 | -47.5% | 0.00% | -55.6% |
| Q1 2017 | $1,523,000 | +126.6% | 24,226 | +90.4% | 0.01% | +200.0% |
| Q4 2016 | $672,000 | -2.2% | 12,726 | 0.0% | 0.00% | -25.0% |
| Q3 2016 | $687,000 | +33.7% | 12,726 | 0.0% | 0.00% | +33.3% |
| Q2 2016 | $514,000 | +15.0% | 12,726 | 0.0% | 0.00% | +50.0% |
| Q1 2016 | $447,000 | -21.7% | 12,726 | 0.0% | 0.00% | -33.3% |
| Q4 2015 | $571,000 | +16.3% | 12,726 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $491,000 | -20.3% | 12,726 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $616,000 | +36.9% | 12,726 | 0.0% | 0.00% | +50.0% |
| Q1 2015 | $450,000 | +10.0% | 12,726 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $409,000 | -13.5% | 12,726 | 0.0% | 0.00% | -33.3% |
| Q3 2014 | $473,000 | -2.9% | 12,726 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $487,000 | -16.0% | 12,726 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $580,000 | +17.9% | 12,726 | +3.1% | 0.00% | 0.0% |
| Q4 2013 | $492,000 | -9.1% | 12,342 | 0.0% | 0.00% | -25.0% |
| Q3 2013 | $541,000 | +38.4% | 12,342 | -0.7% | 0.00% | +33.3% |
| Q2 2013 | $391,000 | – | 12,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
| Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
| Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
| DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
| Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
| Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
| EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
| CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
| Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |